Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR1A | P08908 | 1/20 | 0.65 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.65 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.65 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.65 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.65 |
| ▸ | SLC18A2 | Q05940 | 10/20 | 0.57 |
| ▸ | HTR2A | P28223 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22612151 | 0.93 | HTR1A (0.70) | HTR1ATBXA2RPTGS1OPRM1KCNH2 | |
| SCHEMBL22612169 | 0.93 | HTR1A (0.70) | HTR1ATBXA2RPTGS1OPRM1KCNH2 | |
| SCHEMBL22612168 | 0.93 | HTR1A (0.70) | HTR1ATBXA2RPTGS1OPRM1KCNH2 | |
| SCHEMBL19024413 | 0.93 | HTR1A (0.70) | HTR1ATBXA2RPTGS1OPRM1KCNH2 | |
| SCHEMBL20049853 | 0.93 | HTR1A (0.70) | HTR1ATBXA2RPTGS1OPRM1KCNH2 | |
| SCHEMBL19024412 | 0.93 | HTR1A (0.70) | HTR1ATBXA2RPTGS1OPRM1KCNH2 | |
| SCHEMBL19024411 | 0.93 | HTR1A (0.70) | HTR1ATBXA2RPTGS1OPRM1KCNH2 | |
| SCHEMBL24520555 | 0.88 | HTR1A (0.63) | HTR1ATBXA2RPTGS1OPRM1KCNH2 | |
| SCHEMBL871905 | 0.84 | HTR1A (0.72) | HTR1ATBXA2RPTGS1OPRM1KCNH2 | |
| SCHEMBL29929867 | 0.83 | HTR1A (0.79) | HTR1ATBXA2RPTGS1OPRM1KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2020213014-A1 | AN IMPROVED PROCESS FOR THE PREPARATION OF VALBENAZINE AND ITS SALTS | MYLAN LABORATORIES LIMITED (IN) | 2020-10-22 | — | — | WO | disclosed |